All In MedTech

Device Trial Radar · NCT04574336

Scandinavian Humeral Diaphyseal Fracture Trial

Scandinavian Humeral diAphyseal Fracture Trial - A Pragmatic Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Apr 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 287 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

287

Planned (sponsor's estimate)

Start

Apr 4, 2022

Primary completion

Dec 31, 2025

Study completion Jul 31, 2031

Sponsor

Lead sponsor
Kolding SygehusAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Copenhagen University Hospital, Hvidovre; Zealand University Hospital; Oslo University Hospital; Helse Stavanger HF; Sahlgrenska University Hospital; Uppsala University Hospital; Odense University Hospital; Hospital of Southern Jutland; Slagelse Hospital; Aalborg University Hospital; University Hospital, Umeå; Nordsjaellands Hospital; Holbaek Sygehus; Aarhus University Hospital; Copenhagen University Hospital at Herlev; University Hospital Bispebjerg and Frederiksberg; Viborg Regional Hospital; Karolinska University Hospital; Danderyd Hospital; Tampere University Hospital; Helsinki University Central Hospital
First posted
Oct 5, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pragmatic multicenter randomized controlled trial (RCT) includes adult participants with an acute humeral shaft fracture to compare surgical fixation of humeral shaft fracture to non-surgical treatment with early identification and treatment of delayed union by a patient-reported outcome after 52 weeks. The trial population of 287 participants The trial population is divided in two age-groups due to the changes in DASH score by age. The definition of delayed union differs in the young and elderly population to consider dissimilarity in bone healing rates and the timepoint for crossover is therefor different between the groups. Participants will be randomized 1:1 between non-surgical treatment and surgical treatment. The primary outcome is the Disability of Arm, Shoulder and Hand (DASH) score at 52 weeks, and is assessor blinded. The secondary outcomes are DASH score earlier than 52 weeks, EQ-5D-5L, pain assessed by visual analogue score, Constant-Murley score including elbow range of motion and anchor-questions collected at all timepoints throughout the trial. All complications will be reported including; infection, nerve or vascular injury, surgical revisions (implant malpositioning, hardware failure, aseptic loosening and peri-implant fracture), major adverse cardiovascular events, other major adverse events and mortality. SHAFT will provide information on the effectiveness of two standard treatments for humeral shaft fractures, while taking the dilemmas within the population into account.

Conditions

  • Fracture Humerus of Shaft

Interventions

  • Surgical treatmentProcedure

    We anticipate that surgical treatment will include plate osteosynthesis (MIPO and ORIF), intramedullary nailing (antegrade and retrograde) and external fixation. Plate and nail types, screw configuration and surgical approaches will be decided by the surgeon. The procedure will be conducted or supervised by a senior consultant.

  • Non-surgical treatmentDevice

    Non-surgical treatment will include sugar tong, splint, plaster splints, hanging casts, or functional bracing as the Sarmiento brace and will be worn until a surgeon removes it. If the surgeon deems it appropriate, participants will be offered to undergo early secondary surgery with a surgical procedure of their choice. The participants will be recorded and the reason will be noted. We anticipate the surgical procedures will be similar to the previous mentioned and perhaps with the addition of bone graft.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disabilities of the Arm, Shoulder and Hand (DASH) scoreTime frame: 52 weeks

Locations

22 sites in 4 countries. Site status is shown where the registry gives one.

  • Aabenraa Hospital

    Aabenraa, Denmark · Recruiting

  • Aarhus Hospital

    Aarhus, Denmark · Recruiting

  • Bispebjerg Hospital

    Copenhagen, Denmark · Recruiting

19 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.